“A targeted chemotherapy drug approved for treatment of breast cancer showed clinical benefit in patients with treatment-resistant uterine cancer.
Original story
Continue reading at Yale News
news.yale.edu
Summary generated from the RSS feed of Yale News. All article rights belong to the original publisher. Click through to read the full piece on news.yale.edu.
